Skip to main content
Top
Published in: Molecular and Cellular Pediatrics 1/2020

Open Access 01-12-2020 | Obesity | Mini review

Asprosin in pregnancy and childhood

Authors: Ruth Janoschek, Thorben Hoffmann, Yousef Ashraf Tawfik Morcos, Gerhard Sengle, Jörg Dötsch, Eva Hucklenbruch-Rother

Published in: Molecular and Cellular Pediatrics | Issue 1/2020

Login to get access

Excerpt

The prevalence for childhood overweight and obesity increased steadily in the past decades. Childhood obesity was defined as a disease by the World Health Organization [25] and by the American Medical Association (2013) [7] and is listed in the International Statistical Classification of Diseases and Related Health Problems in (ICD). In 2016 over 340 million children and adolescents, aged 5–19 were overweight or obese and current estimates suggest approximately 38 million children under the age of 5 as overweight or obese [25]. Amongst genetic factors and environmental influences, a variety of perinatal risk factors individually or in combination contributes to the development of infant obesity. Especially maternal pre-pregnancy obesity, excessive gestational weight gain and gestational diabetes result in pathological pregnancy conditions. Insulin resistance (IR), elevated blood glucose levels and hormonal disturbance provoke the malprogramming of infant’s energy metabolism [11]. …
Literature
1.
go back to reference Alan M, Gurlek B, Yilmaz A, Aksit M, Aslanipour B, Gulhan I, Mehmet C, Taner CE (2019) Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 35:220–223CrossRef Alan M, Gurlek B, Yilmaz A, Aksit M, Aslanipour B, Gulhan I, Mehmet C, Taner CE (2019) Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 35:220–223CrossRef
2.
go back to reference Badillo-Suárez PA, Rodríguez-Cruz M, Nieves-Morales X (2017) Impact of Metabolic Hormones Secreted in Human Breast Milk on Nutritional Programming in Childhood Obesity. J Mammary Gland Biol Neoplasia 22:171–191CrossRef Badillo-Suárez PA, Rodríguez-Cruz M, Nieves-Morales X (2017) Impact of Metabolic Hormones Secreted in Human Breast Milk on Nutritional Programming in Childhood Obesity. J Mammary Gland Biol Neoplasia 22:171–191CrossRef
3.
go back to reference Baykus Y, Yavuzkir S, Ustebay S, Ugur K, Deniz R, Aydin S (2019) Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus. Peptides 120:170132CrossRef Baykus Y, Yavuzkir S, Ustebay S, Ugur K, Deniz R, Aydin S (2019) Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus. Peptides 120:170132CrossRef
4.
go back to reference Bielohuby M, Popp S, Bidlingmaier M (2012) A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase. Mol Metab 1:47–60CrossRef Bielohuby M, Popp S, Bidlingmaier M (2012) A guide for measurement of circulating metabolic hormones in rodents: Pitfalls during the pre-analytical phase. Mol Metab 1:47–60CrossRef
5.
go back to reference Chojnowska S, Baran T, Wilińska I, Sienicka P, Cabaj-Wiater I, Knaś M (2018) Human saliva as a diagnostic material. Adv Med Sci 63:185–191CrossRef Chojnowska S, Baran T, Wilińska I, Sienicka P, Cabaj-Wiater I, Knaś M (2018) Human saliva as a diagnostic material. Adv Med Sci 63:185–191CrossRef
6.
go back to reference Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, Saha PK, Lee ME, Phillips KJ, Jain M et al (2017) Asprosin is a centrally acting orexigenic hormone. Nat Med 23:1444–1453CrossRef Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, Saha PK, Lee ME, Phillips KJ, Jain M et al (2017) Asprosin is a centrally acting orexigenic hormone. Nat Med 23:1444–1453CrossRef
7.
go back to reference Farpour-Lambert NJ, Baker JL, Hassapidou M, Holm JC, Nowicka P, O'Malley G, Weiss R (2015) Childhood obesity is a chronic disease demanding specific health care--a position statement from the Childhood Obesity Task Force (COTF) of the European Association for the Study of Obesity (EASO). Obes Facts 8:342–349CrossRef Farpour-Lambert NJ, Baker JL, Hassapidou M, Holm JC, Nowicka P, O'Malley G, Weiss R (2015) Childhood obesity is a chronic disease demanding specific health care--a position statement from the Childhood Obesity Task Force (COTF) of the European Association for the Study of Obesity (EASO). Obes Facts 8:342–349CrossRef
8.
go back to reference Fields DA, George B, Williams M, Whitaker K, Allison DB, Teague A, Demerath EW (2017) Associations between human breast milk hormones and adipocytokines and infant growth and body composition in the first 6 months of life. Pediatr Obes 12(Suppl 1):78–85CrossRef Fields DA, George B, Williams M, Whitaker K, Allison DB, Teague A, Demerath EW (2017) Associations between human breast milk hormones and adipocytokines and infant growth and body composition in the first 6 months of life. Pediatr Obes 12(Suppl 1):78–85CrossRef
10.
go back to reference Gröschl M (2017) Saliva: a reliable sample matrix in bioanalytics. Bioanalysis 9:655–668CrossRef Gröschl M (2017) Saliva: a reliable sample matrix in bioanalytics. Bioanalysis 9:655–668CrossRef
11.
go back to reference Hu Z, Tylavsky FA, Han JC, Kocak M, Fowke JH, Davis RL, Lewinn K, Bush NR, Zhao Q (2019) Maternal metabolic factors during pregnancy predict early childhood growth trajectories and obesity risk: the CANDLE Study. Int J Obes (Lond) (2005) 43:1914–1922CrossRef Hu Z, Tylavsky FA, Han JC, Kocak M, Fowke JH, Davis RL, Lewinn K, Bush NR, Zhao Q (2019) Maternal metabolic factors during pregnancy predict early childhood growth trajectories and obesity risk: the CANDLE Study. Int J Obes (Lond) (2005) 43:1914–1922CrossRef
12.
go back to reference Jung TW, Kim HC, Kim HU, Park T, Park J, Kim U, Kim MK, Jeong JH (2019) Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle. J Cell Physiol 234:20888–20899CrossRef Jung TW, Kim HC, Kim HU, Park T, Park J, Kim U, Kim MK, Jeong JH (2019) Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle. J Cell Physiol 234:20888–20899CrossRef
13.
go back to reference Lee T, Yun S, Jeong JH, Jung TW (2019) Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Mol Cell Endocrinol 486:96–104CrossRef Lee T, Yun S, Jeong JH, Jung TW (2019) Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Mol Cell Endocrinol 486:96–104CrossRef
14.
go back to reference Li E, Shan H, Chen L, Long A, Zhang Y, Liu Y, Jia L, Wei F, Han J, Li T et al (2019) OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metab 30:319–328 e318CrossRef Li E, Shan H, Chen L, Long A, Zhang Y, Liu Y, Jia L, Wei F, Han J, Li T et al (2019) OLFR734 mediates glucose metabolism as a receptor of asprosin. Cell Metab 30:319–328 e318CrossRef
15.
go back to reference Li X, Liao M, Shen R, Zhang L, Hu H, Wu J, Wang X, Qu H, Guo S, Long M et al (2018) Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators Inflamm 2018:7375294PubMedPubMedCentral Li X, Liao M, Shen R, Zhang L, Hu H, Wu J, Wang X, Qu H, Guo S, Long M et al (2018) Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators Inflamm 2018:7375294PubMedPubMedCentral
16.
go back to reference Long W, Xie X, Du C, Zhao Y, Zhang C, Zhan D, Li Z, Ning Q, Luo X (2019) Decreased circulating levels of asprosin in obese children. Horm Res Paediatr 91:271–277CrossRef Long W, Xie X, Du C, Zhao Y, Zhang C, Zhan D, Li Z, Ning Q, Luo X (2019) Decreased circulating levels of asprosin in obese children. Horm Res Paediatr 91:271–277CrossRef
17.
go back to reference Lönnqvist L, Reinhardt D, Sakai L, Peltonen L (1998) Evidence for furin-type activity-mediated C-terminal processing of profibrillin-1 and interference in the processing by certain mutations. Hum Mol Genet 7:2039–2044CrossRef Lönnqvist L, Reinhardt D, Sakai L, Peltonen L (1998) Evidence for furin-type activity-mediated C-terminal processing of profibrillin-1 and interference in the processing by certain mutations. Hum Mol Genet 7:2039–2044CrossRef
18.
go back to reference Muthu ML, Reinhardt DP (2020) Fibrillin-1 and fibrillin-1-derived asprosin in adipose tissue function and metabolic disorders. J Cell Commun Signal 14:159–173CrossRef Muthu ML, Reinhardt DP (2020) Fibrillin-1 and fibrillin-1-derived asprosin in adipose tissue function and metabolic disorders. J Cell Commun Signal 14:159–173CrossRef
19.
go back to reference Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B et al (2016) Asprosin, a fasting-induced glucogenic protein hormone. Cell 165:566–579CrossRef Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B et al (2016) Asprosin, a fasting-induced glucogenic protein hormone. Cell 165:566–579CrossRef
20.
go back to reference Schueler J, Alexander B, Hart AM, Austin K, Larson-Meyer DE (2013) Presence and dynamics of leptin, GLP-1, and PYY in human breast milk at early postpartum. Obesity (Silver Spring, Md) 21:1451–1458CrossRef Schueler J, Alexander B, Hart AM, Austin K, Larson-Meyer DE (2013) Presence and dynamics of leptin, GLP-1, and PYY in human breast milk at early postpartum. Obesity (Silver Spring, Md) 21:1451–1458CrossRef
21.
go back to reference Sünnetçi Silistre E, Hatipoğlu HU (2020) Increased serum circulating asprosin levels in children with obesity. Pediatr Int 62:467–476CrossRef Sünnetçi Silistre E, Hatipoğlu HU (2020) Increased serum circulating asprosin levels in children with obesity. Pediatr Int 62:467–476CrossRef
22.
go back to reference Ugur K, Aydin S (2019) Saliva and blood asprosin hormone concentration associated with obesity. Int J Endocrinol 2019:2521096CrossRef Ugur K, Aydin S (2019) Saliva and blood asprosin hormone concentration associated with obesity. Int J Endocrinol 2019:2521096CrossRef
23.
go back to reference Wang M, Yin C, Wang L, Liu Y, Li H, Li M, Yi X, Xiao Y (2019) Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity. Ann Nutr Metab 75:205–212CrossRef Wang M, Yin C, Wang L, Liu Y, Li H, Li M, Yi X, Xiao Y (2019) Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity. Ann Nutr Metab 75:205–212CrossRef
24.
go back to reference Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, Zheng Y, Zheng H (2018) Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediators Inflamm 2018:9471583PubMedPubMedCentral Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, Zheng Y, Zheng H (2018) Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediators Inflamm 2018:9471583PubMedPubMedCentral
25.
go back to reference WHO (2019). Facts and figures on childhood obesity. WHO (2019). Facts and figures on childhood obesity.
26.
go back to reference Zhong L, Long Y, Wang S, Lian R, Deng L, Ye Z, Wang Z, Liu B (2020) Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: A nested case-control study. Placenta 93:17–22CrossRef Zhong L, Long Y, Wang S, Lian R, Deng L, Ye Z, Wang Z, Liu B (2020) Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: A nested case-control study. Placenta 93:17–22CrossRef
Metadata
Title
Asprosin in pregnancy and childhood
Authors
Ruth Janoschek
Thorben Hoffmann
Yousef Ashraf Tawfik Morcos
Gerhard Sengle
Jörg Dötsch
Eva Hucklenbruch-Rother
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Molecular and Cellular Pediatrics / Issue 1/2020
Electronic ISSN: 2194-7791
DOI
https://doi.org/10.1186/s40348-020-00110-8

Other articles of this Issue 1/2020

Molecular and Cellular Pediatrics 1/2020 Go to the issue